Renowned Researchers and Clinicians at AutismOne 2019 Conference Conducting Studies on ASD Health Questions

AutismOne 2019 Conference, May 22-26, in Chicago features up-to-the-minute scientific information

LOS ANGELES (PRWEB) January 16, 2019

With over 130 speakers spanning a 5-day period, the AutismOne 2019 Conference offers the latest news in health questions related to autism spectrum disorders and how to improve symptoms. Tracks and programs at the event include the PANDAS/PANS track (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections/pediatric acute-onset neuropsychiatric syndrome); the Membrane Medicine track (targeted neurometabolic approach for neurological disorders including autism, seizures, and pervasive developmental disorder using bioactive lipid therapy); and the return of the original 3-day Chiropractic Pediatric Continuing Education Credit Program with Emphasis on Autism).

Clinician and nationally leading autism researcher Richard Frye, MD, PhD, will be speaking on "Metabolic Disorders Associated with Autism" and "The Role of Autoantibodies in Autism Spectrum Disorder and their Treatment." Dr. Frye holds board certifications in pediatrics and in neurology, with special competence in child neurology. He has authored over 150 peer-reviewed publications and book chapters, and he serves on several editorial boards.

Researcher and professor James Adams, PhD, will be speaking on "Comprehensive Nutritional and Dietary Intervention for ASD" and "Microbiota Transplant Therapy for Treating Gastrointestinal Problems in Children with ASD." Dr. Adams is the director of the Autism/Asperger's Research Program at Arizona State University and the co-leader of the Scientific Advisory Committee of the Autism Research Institute. He has published over 150 peer-reviewed scientific articles, including over 40 related to autism.

AutismOne is pleased to share the following information about studies of interest.

Are you the parent of an adult-aged child with autism and gastrointestinal symptoms? Then you may be interested in participation in the following clinical trial overseen by experienced, well-credentialed researchers Richard Frye, MD, PhD, and James Adams, PhD. This health arena, in general, already shows much promise. The purpose of the study is to investigate a new, investigational treatment for gastrointestinal (GI) problems and autism symptoms known as microbial transfer therapy (MTT). More information about "Microbiota Transfer Therapy for Adults with Autism Spectrum Disorder (ASD) who have Gastrointestinal Disorders" can be found at
https://m.facebook.com/PhoenixChildrensHospital/photos/a.125121842437/10156438519127438/?type=3&source=48
and a request to participate can found at
https://www.surveygizmo.com/s3/4399989/Application-Adult-ASD-MTT-PCH

Arizona State University's Autism/Asperger's Research Program is conducting a "National Survey on Evaluation of Marijuana, CBD, and THC Products for ASD."
Background: Marijuana, CBD, and THC products are used by some individuals with ASD, but there is little research on their possible benefits and possible adverse effects.
Study Purpose: To gather survey data on the possible benefits and possible adverse effects of marijuana, CBD, and THC products for ASD
Who can enroll? Adults with ASD, or parents/guardians of individuals with ASD, who have used one or more of these products.
Survey: The survey is anonymous, and will require about 5-10 minutes to complete.
Compensation: none
Participation is voluntary.
Impact: Participation in this study will help us understand the possible benefits and possible adverse effects of marijuana, CBD, and THC products for ASD, and help guide future research on them.
For more information, go to http://autism.asu.edu.

Another IRB-approved study of interest is "The Association between Neurologic Status and Emigration to Mitochondrial Disease and Microbiome Shifts." This is a non-invasive study that will be analyzing the mitochondrial health and polyomics on ASD patients and neurotypicals. Only a few more volunteers are being accepted into the study. Contact Illinois-based Dr. Mark Cannon at drmarkcannon@outlook.com.

The AutismOne 2019 Conference will be held at the beautiful Loews Chicago O'Hare Hotel, just 10 minutes from Chicago O'Hare International Airport, May 22-26, 2019. For more information or to register at a currently remarkably low general conference registration rate, please visit http://www.autismoneconference.com.

For the original version on PRWeb visit: https://www.prweb.com/releases/renowned_researchers_and_clinicians_at_autismone_2019_conference_conducting_studies_on_asd_health_questions/prweb16033938.htm